Memory CD8 T cells, generated by natural pathogen exposure or intentional vaccination, protect the host against specific viral infections1. It has long been proposed that the number of memory CD8 T cells in the host is inflexible, and that individual cells are constantly competing for limited space2,3. Consequently, vaccines that introduce over-abundant quantities of memory CD8 T cells specific for an agent of interest could have catastrophic consequences for the host by displacing memory CD8 T cells specific for all previous infections4,5,6. To test this paradigm, we developed a vaccination regimen in mice that introduced as many new long-lived memory CD8 T cells specific for a single vaccine antigen as there were memory CD8 T cells in the host before vaccination. Here we show that, in contrast to expectations, the size of the memory CD8 T-cell compartment doubled to accommodate these new cells, a change due solely to the addition of effector memory CD8 T cells. This increase did not affect the number of CD4 T cells, B cells or naive CD8 T cells, and pre-existing memory CD8 T cells specific for a previously encountered infection were largely preserved. Thus, the number of effector memory CD8 T cells in the mammalian host adapts according to immunological experience. Developing vaccines that abundantly introduce new memory CD8 T cells should not necessarily ablate pre-existing immunity to other infections.
Subscribe to Journal
Get full journal access for 1 year
only $3.90 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Christensen, J. P., Doherty, P. C., Branum, K. C. & Riberdy, J. M. Profound protection against respiratory challenge with a lethal H7N7 influenza A virus by increasing the magnitude of CD8+ T-cell memory. J. Virol. 74, 11690–11696 (2000)
Freitas, A. A. & Rocha, B. Population biology of lymphocytes: the flight for survival. Annu. Rev. Immunol. 18, 83–111 (2000)
Goldrath, A. W. Maintaining the status quo: T-cell homeostasis. Microbes Infect. 4, 539–545 (2002)
Welsh, R. M., Selin, L. K. & Szomolanyi-Tsuda, E. Immunological memory to viral infections. Annu. Rev. Immunol. 22, 711–743 (2004)
Surh, C. D., Boyman, O., Purton, J. F. & Sprent, J. Homeostasis of memory T cells. Immunol. Rev. 211, 154–163 (2006)
Sad, S. & Krishnan, L. Maintenance and attrition of T-cell memory. Crit. Rev. Immunol. 23, 129–147 (2003)
Masopust, D., Ha, S. J., Vezys, V. & Ahmed, R. Stimulation history dictates memory CD8 T cell phenotype: implications for prime–boost vaccination. J. Immunol. 177, 831–839 (2006)
Woodland, D. L. Jump-starting the immune system: prime–boosting comes of age. Trends Immunol. 25, 98–104 (2004)
Wherry, E. J. et al. Lineage relationship and protective immunity of memory CD8 T cell subsets. Nature Immunol. 4, 225–234 (2003)
Selin, L. K., Vergilis, K., Welsh, R. M. & Nahill, S. R. Reduction of otherwise remarkably stable virus-specific cytotoxic T lymphocyte memory by heterologous viral infections. J. Exp. Med. 183, 2489–2499 (1996)
Selin, L. K. et al. Attrition of T cell memory: selective loss of LCMV epitope-specific memory CD8 T cells following infections with heterologous viruses. Immunity 11, 733–742 (1999)
Schluns, K. S. & Lefrancois, L. Cytokine control of memory T-cell development and survival. Nature Rev. Immunol. 3, 269–279 (2003)
Masopust, D., Vezys, V., Wherry, E. J., Barber, D. L. & Ahmed, R. Cutting edge: gut microenvironment promotes differentiation of a unique memory CD8 T cell population. J. Immunol. 176, 2079–2083 (2006)
Jabbari, A. & Harty, J. T. Secondary memory CD8+ T cells are more protective but slower to acquire a central-memory phenotype. J. Exp. Med. 203, 919–932 (2006)
Antia, R., Ganusov, V. V. & Ahmed, R. The role of models in understanding CD8+ T-cell memory. Nature Rev. Immunol. 5, 101–111 (2005)
Jackola, D. R. & Hallgren, H. M. Dynamic phenotypic restructuring of the CD4 and CD8 T-cell subsets with age in healthy humans: a compartmental model analysis. Mech. Ageing Dev. 105, 241–264 (1998)
Czesnikiewicz-Guzik, M. et al. T cell subset-specific susceptibility to aging. Clin. Immunol. 127, 107–118 (2008)
Hammarlund, E. et al. Duration of antiviral immunity after smallpox vaccination. Nature Med. 9, 1131–1137 (2003)
Pantaleo, G. & Koup, R. A. Correlates of immune protection in HIV-1 infection: what we know, what we don’t know, what we should know. Nature Med. 10, 806–810 (2004)
Sekaly, R. P. The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? J. Exp. Med. 205, 7–12 (2008)
Kaiser, J. AIDS research. Review of vaccine failure prompts a return to basics. Science 320, 30–31 (2008)
Shiver, J. W. & Emini, E. A. Recent advances in the development of HIV-1 vaccines using replication-incompetent adenovirus vectors. Annu. Rev. Med. 55, 355–372 (2004)
Lefrancois, L., Olson, S. & Masopust, D. A critical role for CD40–CD40 ligand interactions in amplification of the mucosal CD8 T cell response. J. Exp. Med. 190, 1275–1284 (1999)
Murali-Krishna, K. et al. Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177–187 (1998)
Hunter, R. L., Kidd, M. R., Olsen, M. R., Patterson, P. S. & Lal, A. A. Induction of long-lasting immunity to Plasmodium yoelii malaria with whole blood-stage antigens and copolymer adjuvants. J. Immunol. 154, 1762–1769 (1995)
Slifka, M. K., Matloubian, M. & Ahmed, R. Bone marrow is a major site of long-term antibody production after acute viral infection. J. Virol. 69, 1895–1902 (1995)
We thank S. Jameson, E. J. Wherry and A. Haase for critical discussions and reading of the manuscript, and J. W. Yewdell for recombinant vaccinia virus. This research was supported by start-up funds from the University of Minnesota Medical School (V.V. and D.M.) and NIH grant AI30048 (R. Ahmed).
About this article
Cite this article
Vezys, V., Yates, A., Casey, K. et al. Memory CD8 T-cell compartment grows in size with immunological experience. Nature 457, 196–199 (2009) doi:10.1038/nature07486
The Journal of Immunology (2019)
Frontiers in Immunology (2019)
Pleurotus ferulae polysaccharides improve the antitumor efficacy of therapeutic human papillomavirus dendritic cell-based vaccine
Human Vaccines & Immunotherapeutics (2019)
Frontiers in Neurology (2019)
Vaccine induction of antibodies and tissue-resident CD8+ T cells enhances protection against mucosal SHIV-infection in young macaques
JCI Insight (2019)